Literature DB >> 2358594

Naturally occurring cardiomyopathy in the Doberman pinscher: a possible large animal model of human cardiomyopathy?

M L Smucker1, S Kaul, J A Woodfield, J C Keith, S A Manning, J A Gascho.   

Abstract

Currently there is no large animal model of dilated cardiomyopathy. The smaller animal models of cardiomyopathy, such as the Syrian hamster, cannot be studied with echocardiography and cardiac catheterization, and the relevance of these models to human dilated cardiomyopathy is open to question. On the basis of some initial observations in Doberman pinschers, it was speculated that these dogs could have occult left ventricular dysfunction. Accordingly, studies were performed in 46 apparently healthy Doberman pinschers and in 41 mongrel dogs: two-dimensional echocardiography (30 dogs in each group), cardiac catheterization (16 Doberman pinschers and 12 mongrels) and coronary blood flow studies (13 Doberman pinschers and 6 mongrels). In the awake, unsedated dogs studied with echocardiography, left ventricular wall thickening was significantly less in the Dobermans than in the mongrels (28% versus 36%, p = 0.0003). In the anesthetized dogs undergoing cardiac catheterization, left ventricular ejection fraction was significantly lower in the Dobermans than in the mongrels (0.38 versus 0.63, p = 0.0001). Rest coronary blood flow and coronary blood flow reserve were similar in the two groups. It is concluded that apparently healthy Doberman pinschers have occult left ventricular dysfunction. These dogs may serve as a large animal model of dilated cardiomyopathy and should not be used experimentally to study normal cardiac physiology.

Entities:  

Mesh:

Year:  1990        PMID: 2358594     DOI: 10.1016/0735-1097(90)90480-d

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  A splice site mutation in a gene encoding for PDK4, a mitochondrial protein, is associated with the development of dilated cardiomyopathy in the Doberman pinscher.

Authors:  Kathryn M Meurs; Sunshine Lahmers; Bruce W Keene; Stephen N White; Mark A Oyama; Evan Mauceli; Kerstin Lindblad-Toh
Journal:  Hum Genet       Date:  2012-03-25       Impact factor: 4.132

2.  Heart rate variability in the dog: is it too variable?

Authors:  S L Minors; M R O'Grady
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

3.  Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs is associated with calstabin2 deficiency.

Authors:  Mark A Oyama; Steve Reiken; Stephan E Lehnart; Sridar V Chittur; Kathryn M Meurs; Joshua Stern; Andrew R Marks
Journal:  J Vet Cardiol       Date:  2008-06-02       Impact factor: 1.701

4.  Cardiac regenerative potential of cardiosphere-derived cells from adult dog hearts.

Authors:  Michael Taylor Hensley; James de Andrade; Bruce Keene; Kathryn Meurs; Junnan Tang; Zegen Wang; Thomas G Caranasos; Jorge Piedrahita; Tao-Sheng Li; Ke Cheng
Journal:  J Cell Mol Med       Date:  2015-04-09       Impact factor: 5.310

5.  Relation of vitamin D status to congestive heart failure and cardiovascular events in dogs.

Authors:  M S Kraus; K M Rassnick; J J Wakshlag; A R M Gelzer; A S Waxman; A M Struble; K Refsal
Journal:  J Vet Intern Med       Date:  2013-11-07       Impact factor: 3.333

6.  Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy.

Authors:  Michael Taylor Hensley; Junnan Tang; Kathleen Woodruff; Teresa Defrancesco; Sandra Tou; Christina M Williams; Mathew Breen; Kathryn Meurs; Bruce Keene; Ke Cheng
Journal:  J Cell Mol Med       Date:  2017-03-15       Impact factor: 5.310

7.  The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman  Pinschers of efficacy and outcomes.

Authors:  Sabine Werner; Gerd Wallukat; Niels-Peter Becker; Katrin Wenzel; Johannes Müller; Ingolf Schimke; Gerhard Wess
Journal:  ESC Heart Fail       Date:  2020-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.